Compare J.B.Chemicals with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PROCTER & GAMBLE HEALTH - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PROCTER & GAMBLE HEALTH J.B.CHEMICALS/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 21.3 42.0 50.6% View Chart
P/BV x 3.8 4.3 88.3% View Chart
Dividend Yield % 0.3 11.0 2.8%  

Financials

 J.B.CHEMICALS   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
PROCTER & GAMBLE HEALTH
Dec-18
J.B.CHEMICALS/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs3633,549 10.2%   
Low Rs2551,301 19.6%   
Sales per share (Unadj.) Rs169.1511.4 33.1%  
Earnings per share (Unadj.) Rs16.661.3 27.1%  
Cash flow per share (Unadj.) Rs23.474.0 31.6%  
Dividends per share (Unadj.) Rs2.00440.00 0.5%  
Dividend yield (eoy) %0.618.1 3.6%  
Book value per share (Unadj.) Rs172.5927.8 18.6%  
Shares outstanding (eoy) m83.5716.60 503.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.84.7 38.5%   
Avg P/E ratio x18.639.6 47.1%  
P/CF ratio (eoy) x13.232.8 40.3%  
Price / Book Value ratio x1.82.6 68.5%  
Dividend payout %12.0717.9 1.7%   
Avg Mkt Cap Rs m25,82740,257 64.2%   
No. of employees `0003.81.1 332.6%   
Total wages/salary Rs m2,5111,313 191.3%   
Avg. sales/employee Rs Th3,747.47,486.7 50.1%   
Avg. wages/employee Rs Th665.71,157.6 57.5%   
Avg. net profit/employee Rs Th367.8897.2 41.0%   
INCOME DATA
Net Sales Rs m14,1358,490 166.5%  
Other income Rs m366244 150.0%   
Total revenues Rs m14,5018,734 166.0%   
Gross profit Rs m2,1781,482 147.0%  
Depreciation Rs m570211 269.7%   
Interest Rs m350-   
Profit before tax Rs m1,9401,514 128.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m552563 98.2%   
Profit after tax Rs m1,3871,017 136.3%  
Gross profit margin %15.417.5 88.3%  
Effective tax rate %28.537.1 76.7%   
Net profit margin %9.812.0 81.9%  
BALANCE SHEET DATA
Current assets Rs m10,47015,343 68.2%   
Current liabilities Rs m2,7491,960 140.2%   
Net working cap to sales %54.6157.6 34.7%  
Current ratio x3.87.8 48.7%  
Inventory Days Days5549 113.3%  
Debtors Days Days7828 273.0%  
Net fixed assets Rs m5,8111,209 480.5%   
Share capital Rs m167166 100.7%   
"Free" reserves Rs m14,24815,235 93.5%   
Net worth Rs m14,41615,401 93.6%   
Long term debt Rs m00-   
Total assets Rs m17,64917,595 100.3%  
Interest coverage x56.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 166.0%   
Return on assets %8.15.8 139.3%  
Return on equity %9.66.6 145.7%  
Return on capital %13.710.3 133.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,1641,636 376.7%   
Fx outflow Rs m1,3344,368 30.5%   
Net fx Rs m4,829-2,732 -176.8%   
CASH FLOW
From Operations Rs m1,231-1,304 -94.4%  
From Investments Rs m-20812,697 -1.6%  
From Financial Activity Rs m-595-301 198.1%  
Net Cashflow Rs m42711,093 3.9%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 51.8 0.6%  
Indian inst/Mut Fund % 3.4 18.2 18.6%  
FIIs % 3.9 1.0 390.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 29.1 127.1%  
Shareholders   30,437 28,591 106.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   TTK HEALTHCARE  SUVEN LIFESCIENCES  STERLING BIOTECH  ELDER PHARMA  ALEMBIC LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms Over 600 Points; Nifty Trades Above 9,200 Mark(01:30 pm)

Share markets in India have extended early gains and are presently trading on a strong note, lifted by private banks and finance stocks.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

Protect Your Wealth from Fund Managers(Fast Profits Daily)

May 14, 2020

Do you know how much you are paying in fees to your mutual fund? In this video I'll share with you my views.

How Commodity Prices Tell You When Stocks Will Go Up(Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

Why Buffet - and you - should study Quantum Liquid Fund(The Honest Truth)

May 14, 2020

Ajit Dayal on how Quantum Liquid Fund and Warren Buffett have similar investing styles.

More

Get Rich as the
Market Rebounds from Covid-19

Coronavirus Rebound
Get this special guide, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


May 27, 2020 02:09 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS